Companies Dominating the Drug Testing Equipment Landscape
- Sandoz International GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Quest Diagnostics Incorporated
- Butterfly Network, Inc.
- F. Hoffmann-La Roche
- Thermo Fisher Scientific, Inc.
- Siemens AG
- Bio-Rad Laboratories, Inc.
- Cordant Health Solutions
- Legacy Medical Services, LLC
- Omega Laboratories, Inc.
- GE Healthcare
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of drug testing equipment is estimated at USD 8.82 billion.
The drug testing equipment market size was valued at USD 7.43 billion in 2024 and is likely to cross USD 29.54 billion by 2037, registering more than 11.2% CAGR during the forecast period i.e., between 2025-2037. The rising use of intoxicants and controlled substances and the rising misuse of prescribed medicines will boost the market growth.
North America industry is anticipated to account for largest revenue share of 40% by 2037, driven by existence of giant players in the industry encouraging drug screening in the region.
The major players in the market are Sandoz International GmbH, Quest Diagnostics Incorporated, Butterfly Network, Inc., F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc., GE Healthcare
